These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15093813)
1. 131I-recombinant human EGF has antitumor effects against MCF-7 human breast cancer xenografts with low levels of EGFR. Li YC; Xu WY; Tan TZ; He S Nucl Med Biol; 2004 May; 31(4):435-40. PubMed ID: 15093813 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Chen P; Cameron R; Wang J; Vallis KA; Reilly RM J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194 [TBL] [Abstract][Full Text] [Related]
3. [Radiobiological effect of 131I radiolabeled recombinant human epidermal growth factor on nude mice with human breast cancer]. Li Y; Xu W; Tan T; He S Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):749-53. PubMed ID: 16156265 [TBL] [Abstract][Full Text] [Related]
4. [Experimental research into the inhibitory effect of 131I-recombinant human epidermal growth factor on the growth of breast cancer in vivo]. Li Y; Xu W; Tan T; He S Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):444-8. PubMed ID: 15250153 [TBL] [Abstract][Full Text] [Related]
5. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315 [TBL] [Abstract][Full Text] [Related]
6. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice. Kubota T; Josui K; Fukutomi T; Kitajima M Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008 [TBL] [Abstract][Full Text] [Related]
7. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715 [TBL] [Abstract][Full Text] [Related]
8. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent. Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393 [TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice. Murayama Y Ann Surg; 1990 Mar; 211(3):263-8. PubMed ID: 2155590 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy. Fonge H; Lee H; Reilly RM; Allen C Mol Pharm; 2010 Feb; 7(1):177-86. PubMed ID: 19924993 [TBL] [Abstract][Full Text] [Related]
12. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance. Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333 [TBL] [Abstract][Full Text] [Related]
14. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice. Lin YJ; Zhen YS Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947 [TBL] [Abstract][Full Text] [Related]
16. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
17. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma. Boskovitz A; Akabani GH; Pegram CN; Bigner DD; Zalutsky MR Nucl Med Biol; 2004 Apr; 31(3):345-55. PubMed ID: 15028247 [TBL] [Abstract][Full Text] [Related]
18. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735 [TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2. Li L; Xu HY; Mi L; Bian HJ; Qin J; Xiong H; Feng Q; Wen N; Tian R; Xu LQ; Shen XM; Tang H; Chen ZN Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1238-44. PubMed ID: 16979831 [TBL] [Abstract][Full Text] [Related]
20. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]